Natriumhydrogencarbonat-Lösung Fresenius Kabi Deutschland (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Natriumhydrogencarbonat-Lösung Fresenius Kabi Deutschland, is an alkalizing agent presented as a solution for injection for intravenous use. It is employed to correct metabolic acidosis, assist in severe hyperkalemia management, and alkalinize urine in various acid‑base disorders. GNH USA supplies Natriumhydrogencarbonat-Lösung Fresenius Kabi Deutschland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Sodium hydrogen carbonate is used in clinical settings to address disorders of acid‑base balance and related electrolyte disturbances. - Metabolic acidosis: raises systemic pH by providing bicarbonate ions, helping restore normal acid‑base status. - Severe hyperkalemia (as part of therapy): shifts potassium into cells and supports cardiac stability when combined with other measures. - Alkalinization of urine: increases urinary pH to promote excretion of certain toxins or to prevent crystal formation.

Adverse reactions may occur with intravenous administration of sodium hydrogen carbonate.

Common Side Effects: - Mild pain or irritation at the injection site. - Transient hypernatremia due to sodium load. - Mild metabolic alkalosis if over‑corrected. - Fluid overload in patients with limited cardiac reserve. - Hypokalemia secondary to intracellular potassium shift.

Serious or Rare Side Effects: - Severe metabolic alkalosis leading to respiratory depression. - Pulmonary edema in volume‑overloaded patients. - Cardiac arrhythmias from electrolyte disturbances. - Severe hypernatremia causing neurologic symptoms. - Anaphylactoid reactions (rare).

When using sodium hydrogen carbonate injection, clinicians should observe several safety measures. - Assess acid‑base status: verify indication and baseline pH before infusion. - Monitor electrolytes: check serum sodium, potassium, and calcium regularly. - Adjust infusion rate: administer slowly to avoid rapid pH shifts. - Caution in heart failure: limit volume to prevent overload. - Avoid in severe hypocalcemia: may exacerbate calcium deficiency. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Sodium hydrogen carbonate can influence the activity of other medications.

Major Interactions (Avoid): - Concurrent alkalinizing agents (e.g., other bicarbonate solutions) – risk of severe alkalosis. - Calcium‑containing IV solutions – may precipitate calcium carbonate. - Certain antibiotics (e.g., tetracyclines, fluoroquinolones) – reduced absorption/effectiveness.

Moderate Interactions (Monitor Closely): - Potassium supplements – may cause rapid shifts in serum potassium. - Loop diuretics – enhanced electrolyte loss requiring monitoring. - ACE inhibitors or ARBs – increased risk of hyperkalemia when combined with other therapies. - Digitalis glycosides – electrolyte changes can predispose to toxicity.